BioSpace News Archive

The addition of two more US patents to ARANZ Medical’s portfolio of skin surface measurement products further strengthen and secure the company’s IP and product lines.

Significantly Expands Aveanna’s Presence in the Attractive California Market

Loretta Schoen shares her experience and insights in a new book titled, Surviving Medical Mayhem - Laughing When it Hurts, published by HigherLife. In the book Loretta explores, educates and empowers the reader to manage the medical system maze with confidence.

Curis, Inc. announced that on July 2, 2018, , the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase 12,000 shares of Curis common stock to a new employee, with a grant date of July 2, 2018

Shirell A. Gross, Esq., Vice-President and Head of Law for Bayer Pharmaceuticals, Radiology, has been recognized by Savoy Magazine as one of their 2018 Most Influential Black Lawyers.

Walmart, Sam’s Club pharmacists to participate in online program

Company Unveils New Name After Acquiring Integer’s Advanced Surgical and Orthopedics Business

Potrero Medical, Inc., a predictive health company focused on using smart sensors and analytics for early detection of critical illnesses, announced today the closing of a $26.6 million Series C financing.

Dr. Kathleen Anne Welsh-Bohmer, Professor of Psychiatry and Neurology at Duke University, joins the accomplished scientific team at NeuroCog Trials (NCT) providing thought leadership in Neurodegenerative Disorders.

LPLV marks the final steps toward completion of TLC599 trial for osteoarthritis (OA) pain Phase II topline results on-track for 2018 release Set to initiate enrollment of US Phase II pharmacokinetic (PK) trial for TLC599 Clearance received from the U.S. Food and Drug Administration (FDA) for the TLC590 and TLC178 Investigational New Drug (IND) applications, allowing Phase I/II trials to proceed in the...